WallStSmart
SRRK

Scholar Rock Holding Corp

NASDAQ: SRRK · HEALTHCARE · BIOTECHNOLOGY

$46.30
-0.92% today

Updated 2026-04-29

Market cap
$5.57B
P/E ratio
P/S ratio
13.14x
EPS (TTM)
$-3.29
Dividend yield
52W range
$27 – $52
Volume
1.6M

Scholar Rock Holding Corp (SRRK) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$379000.00$0.00$0.00$20.49M$15.40M$18.82M$33.19M$0.00$0.00$0.00
Revenue growth (YoY)-100.0%-24.8%+22.2%+76.4%-100.0%
Cost of revenue$12.48M$669000.00$36.31M$54.22M$74.06M$108.47M$9.88M$2.84M$1.94M$1.66M
Gross profit$-12.10M$-669000.00$-36.31M$20.49M$15.40M$-89.65M$33.19M$-2.84M$-1.94M$-1.66M
Gross margin-3192.1%100.0%100.0%-476.5%100.0%
R&D$12.48M$19.94M$36.31M$54.22M$74.06M$108.47M$124.44M$119.06M$182.61M$206.78M
SG&A$4.11M$5.08M$14.38M$20.82M$28.22M$40.27M$43.12M$49.40M$67.50M$176.21M
Operating income$-16.21M$-25.03M$-50.69M$-54.54M$-86.88M$-129.92M$-134.37M$-171.29M$-252.05M$-384.64M
Operating margin-4277.0%-266.2%-564.0%-690.5%-404.8%
EBITDA$-15.63M$-24.36M$-49.88M$-53.24M$-85.39M$-127.29M$-131.38M$-162.94M$-237.52M$-369.39M
EBITDA margin-4125.3%-259.8%-554.4%-676.5%-395.8%
EBIT$-16.21M$-25.03M$-50.69M$-54.54M$-86.88M$-129.92M$-134.37M$-165.79M$-239.46M$-371.05M
Interest expense$19000.00$0.00$0.00$0.00$0.00$1.88M$2.85M$6.84M$6.89M
Income tax$19000.00$-44000.00$1.37M$-1.30M$-1.49M$2.39M$-2.85M$2.68M
Effective tax rate-0.1%0.2%-2.8%2.6%1.7%-1.8%2.1%-1.6%0.0%0.0%
Net income$-16.21M$-25.00M$-49.33M$-49.70M$-84.99M$-131.80M$-131.65M$-165.79M$-246.29M$-377.94M
Net income growth (YoY)-54.2%-97.3%-0.8%-71.0%-55.1%+0.1%-25.9%-48.6%-53.5%
Profit margin-4276.3%-242.5%-551.8%-700.5%-396.6%